US drugs-giant to acquire Akzo Nobel's Organon for $14.4 billion
Made Popular Mar 13 2007
Schering-Plough, the leading US drugs firm, has agreed to buy Akzo Nobel NV’s drugs unit Organon BioSciences for $14.4 billion in a bid to gain scale and diversify away from cholesterol medicine. The cash sale has marked last-minute reversal...
Add your Comment
Home

Delicious
Digg
Facebook
Reddit
Stumble Upon
Technorati
Mixx
Sphinn
Twitter
SphereIt
Propeller
Gmarks
Newsvine
Yahoo! My Web
Live Journal
Blinklist
E-mail



